TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive More Changes In Carcinogenesis Program At NCI: Gori, Workshops Out, Branch Chiefs Running It November 18, 1977
TCL Archive In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR April 15, 1994